DUTASTERIDE 

                                Enhancing Hair Restoration: The Role of Dutasteride and Bicalutamide

Product Overview

Dual 5-Alpha Reductase Inhibitor for Androgenetic Alopecia (AGA)

Androgenetic alopecia is primarily driven by dihydrotestosterone (DHT), which shortens the anagen phase and leads to progressive follicular miniaturization. Dutasteride inhibits both Type I and Type II 5-alpha reductase enzymes, resulting in a significant reduction in scalp DHT levels and improved follicular preservation. Liposomal delivery enhances follicular targeting while minimizing systemic exposure.

Key Benefits

· Most comfortable Injectable Dutasteride DUTASTERIDE 0.01% IN LIPOSOMES

· Effectively reduces scalp DHT levels

· Slows progression of follicular miniaturization

· Promotes thicker, stronger hair regrowth

· Demonstrates superior efficacy compared to finasteride

· Long half-life ensures sustained therapeutic effect

· Well tolerated in mesotherapy with reduced systemic side effects

 Key Mechanism & Role

· Dutasteride

· Dual inhibition of Type I & II 5-alpha reductase

· Prevents conversion of testosterone to DHT

· Prolongs the anagen (growth) phase of the hair cycle

· Improves hair density and follicle longevity in AGA

· Recommended Usage Guidelines

· Mesotherapy sessions every 1–2 months, or as directed by the treating physician.